Search

Your search keyword '"DE ANGELIS R"' showing total 49 results

Search Constraints

Start Over You searched for: Author "DE ANGELIS R" Remove constraint Author: "DE ANGELIS R" Topic medicine.disease Remove constraint Topic: medicine.disease
49 results on '"DE ANGELIS R"'

Search Results

1. Changes in life expectancy for cancer patients over time since diagnosis

2. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

3. Prognosis and cure of long-term cancer survivors: A population-based estimation

4. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

5. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

6. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

7. Data quality in rare cancers registraton: The report of the RARECARE data quality study

8. Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability

9. The advantage of women in cancer survival: An analysis of EUROCARE-4 data

10. Cancer survival in five continents: a worldwide population-based study (CONCORD)

11. Childhood cancer survival in Europe

12. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

13. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century

14. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

15. Role of Cardiovascular Comorbidity and Depressive Symptoms on One-Year Clinical Progression of Alzheimer’s Disease (AD) in a Population of Italian Elderly

16. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

17. Estimating Relative Survival of Italian Cancer Patients from Sparse Cancer Registries Data

18. Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

19. Predictions of survival up to 10 years after diagnosis for european women with breast cancer in 2000-2002

20. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe

21. Oesophageal cancer survival in Europe: A EUROCARE-4 study

22. Rare cancers are not so rare: the rare cancer burden in Europe

23. Survival of European patients with central nervous system tumors

24. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project

25. Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project

26. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary

27. The cure of cancer: a european perspective

28. Long-term survival expectations of cancer patients in Europe in 2000-2002

29. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States

30. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study

31. Survival from rare cancer in adults: a population-based study

32. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis

33. Incidence, mortality and prevalence of stomach cancer in Italian regions

34. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology

35. Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases

36. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

37. Dietary Changes During COVID-19 Lockdown in Adults With Type 1 Diabetes on a Hybrid Artificial Pancreas

38. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group

39. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments

40. Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting

41. Epidemiology of rare cancers and inequalities in oncologic outcomes

42. Treatment challenges in and outside a network setting: Soft tissue sarcomas

43. Global surveillance of trends in cancer survival 2000-14 (concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

44. Treatment challenges in and outside a network setting: Head and neck cancers

45. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

46. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

47. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999- 2007: Results of EUROCARE-5

48. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods

49. Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study

Catalog

Books, media, physical & digital resources